NASDAQ:HTGM

HTG Molecular Diagnostics Short Interest Ratio and Short Volume

$4.00
-0.28 (-6.54 %)
(As of 04/20/2021 12:00 AM ET)
Add
Compare
Today's Range
$3.94
Now: $4.00
$4.28
50-Day Range
$4.28
MA: $5.55
$6.34
52-Week Range
$3.78
Now: $4.00
$13.80
Volume85,770 shs
Average Volume157,751 shs
Market Capitalization$24.86 million
P/E RatioN/A
Dividend YieldN/A
Beta1.63

Short Interest

HTG Molecular Diagnostics (NASDAQ:HTGM) Short Interest Data

Current Short Volume95,400 shares
Previous Short Volume60,700 shares
Change Vs. Previous Month+57.17%
Dollar Volume Sold Short$471,276.00
Short Interest Ratio / Days to Cover0.7
Last Record DateMarch, 31 2021
Outstanding Shares28,710,000 shares
Float Size5,500,000 shares
Short Percent of Float1.73%
Today's Trading Volume85,770 shares
Average Trading Volume157,751 shares
Today's Volume Vs. Average-45.63%

Short Interest Over Time


HTG Molecular Diagnostics (NASDAQ:HTGM) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/202195,400 shares $471,276.00 +57.2%1.7%0.7 $4.94
3/15/202160,700 shares $342,955.00 +158.3%1.5%0.4 $5.65
2/26/202123,500 shares $135,595.00 -40.4%0.6%0.1 $5.77
2/12/202139,400 shares $218,670.00 -73.1%0.9%0.2 $5.55
1/29/2021146,300 shares $1.03 million -0.5%3.8%0.7 $7.03
1/15/2021147,000 shares $933,450.00 -27.2%3.8%0.7 $6.35
12/31/2020234,200 shares $1.42 million +94.7%6.0%1.3 $6.06
12/15/2020234,200 shares $1.43 million +94.7%6.0%1.3 $6.10
11/30/2020120,300 shares $607,515.00 -92.6%3.1%0.6 $5.05
11/15/20201,630,000 shares $8.85 million -5.8%N/A8.8 $5.43
10/30/20201,730,000 shares $501,700.00 +36.2%N/A0.7 $0.29
10/15/20201,270,000 shares $393,700.00 -9.3%N/A0.4 $0.31
9/30/20201,400,000 shares $462,000.00 -28.2%N/A0.4 $0.33
9/15/20201,950,000 shares $624,000.00 +0.5%N/A0.5 $0.32
8/31/20201,940,000 shares $620,800.00 +407.7%N/A0.4 $0.32
8/14/2020382,100 shares $133,735.00 -23.3%N/A0.1 $0.35
7/31/2020498,200 shares $229,172.00 -62.3%N/A0.1 $0.46
7/15/20201,320,000 shares $871,200.00 +24.5%N/A0.2 $0.66
6/30/20201,060,000 shares $689,000.00 +43.2%N/A0.2 $0.65
6/15/2020740,300 shares $496,001.00 +5.3%N/A0.2 $0.67
5/29/2020702,800 shares $555,212.00 -20.9%N/A0.2 $0.79
5/15/2020888,300 shares $470,799.00 -27.2%N/A0.4 $0.53
4/30/20201,220,000 shares $732,000.00 -17.6%N/A1.1 $0.60
4/15/20201,480,000 shares $592,000.00 -8.6%N/A1.5 $0.40
3/31/20201,620,000 shares $550,800.00 -16.1%N/A1.8 $0.34

HTG Molecular Diagnostics (NASDAQ:HTGM) Short Interest FAQ

speech bubbles
speech bubbles











What is HTG Molecular Diagnostics' current short interest?

Short interest is the volume of HTG Molecular Diagnostics shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 95,400 shares of HTGM short. 1.73% of HTG Molecular Diagnostics' shares are currently sold short. View details.

What is a good short interest ratio for HTG Molecular Diagnostics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HTG Molecular Diagnostics currently has a short interest ratio of 1.0.

What is a good short interest percentage for HTG Molecular Diagnostics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.73% of HTG Molecular Diagnostics' floating shares are currently sold short.

Is HTG Molecular Diagnostics' short interest increasing or decreasing?

HTG Molecular Diagnostics saw a increase in short interest in March. As of March 31st, there was short interest totaling 95,400 shares, an increase of 57.2% from the previous total of 60,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is HTG Molecular Diagnostics' float size?

HTG Molecular Diagnostics currently has issued a total of 6,214,000 shares. Some of HTG Molecular Diagnostics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. HTG Molecular Diagnostics currently has a public float of 5,500,000 shares.

How does HTG Molecular Diagnostics' short interest compare to its competitors?

1.73% of HTG Molecular Diagnostics' shares are currently sold short. Here is how the short interest of companies in the industry of "analytical instruments" compare to HTG Molecular Diagnostics: Illumina, Inc. (2.16%), Agilent Technologies, Inc. (0.88%), Mettler-Toledo International Inc. (1.89%), 10x Genomics, Inc. (2.44%), Bio-Rad Laboratories, Inc. (2.54%), Waters Co. (2.12%), Avantor, Inc. (3.24%), PerkinElmer, Inc. (0.00%), Bruker Co. (1.82%), and Coherent, Inc. (6.14%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Analog Devices, Inc. ($5.84 billion), Aon plc ($5.47 billion), Charter Communications, Inc. ($5.36 billion), ViacomCBS Inc. ($3.99 billion), Snap Inc. ($3.77 billion), Airbnb, Inc. ($2.90 billion), Peloton Interactive, Inc. ($2.43 billion), Discovery, Inc. ($2.38 billion), The Kroger Co. ($2.28 billion), and Expedia Group, Inc. ($2.18 billion). View all of the most shorted stocks.

What does it mean to sell short HTG Molecular Diagnostics stock?

Short selling HTGM is an investing strategy that aims to generate trading profit from HTG Molecular Diagnostics as its price is falling. HTG Molecular Diagnostics' stock is trading down $0.28 today. To short HTG Molecular Diagnostics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that HTG Molecular Diagnostics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against HTG Molecular Diagnostics?

A short squeeze for HTG Molecular Diagnostics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HTGM, which in turn drives the price of the stock up even further.

How often is HTG Molecular Diagnostics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HTGM, twice per month. The most recent reporting period available is March, 31 2021.



This page was last updated on 4/21/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.